Financial Ratios

TITAN BIO-TECH LTD.

NSE : NABSE : 524717ISIN CODE : INE150C01011Industry : ChemicalsHouse : Private
BSE490.60-5.75 (-1.16 %)
PREV CLOSE ( ) 496.35
OPEN PRICE ( ) 497.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15635
TODAY'S LOW / HIGH ( )487.35 507.95
52 WK LOW / HIGH ( ) 228.05618
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)25.4426.2434.827.503.73
   CEPS(Rs)28.5929.1137.369.625.76
   DPS(Rs)1.801.501.501.000.00
   Book NAV/Share(Rs)128.38104.3679.6545.7638.31
   Tax Rate(%)25.2225.1525.7724.7629.28
Margin Ratios
   Core EBITDA Margin(%)20.5025.3134.1915.6512.82
   EBIT Margin(%)20.0424.1532.7414.6211.05
   Pre Tax Margin(%)19.5323.4531.6511.867.48
   PAT Margin (%)14.6017.5523.508.935.29
   Cash Profit Margin (%)16.4119.4725.2111.448.17
Performance Ratios
   ROA(%)16.6220.5535.399.735.28
   ROE(%)21.8628.5255.5317.8511.01
   ROCE(%)27.9035.4861.6318.6312.50
   Asset Turnover(x)1.141.171.511.091.00
   Sales/Fixed Asset(x)2.842.823.332.032.21
   Working Capital/Sales(x)3.002.643.493.213.25
Efficiency Ratios
   Fixed Capital/Sales(x)0.350.350.300.490.45
   Receivable days47.3647.9739.7348.2749.74
   Inventory Days89.7990.8675.96115.84116.42
   Payable days25.3921.7023.4828.4918.64
Valuation Parameters
   PER(x)7.749.995.335.6812.07
   PCE(x)6.899.004.974.447.82
   Price/Book(x)1.532.512.330.931.17
   Yield(%)0.910.570.812.340.00
   EV/Net Sales(x)1.141.761.280.740.98
   EV/Core EBITDA(x)5.246.753.684.557.04
   EV/EBIT(x)5.717.283.915.068.87
   EV/CE(x)1.201.891.630.770.94
   M Cap / Sales1.131.751.250.510.64
Growth Ratio
   Net Sales Growth(%)16.550.8976.2619.294.88
   Core EBITDA Growth(%)-2.32-24.26276.8139.0615.34
   EBIT Growth(%)-3.28-25.58294.8757.725.05
   PAT Growth(%)-3.04-24.64363.97101.3228.28
   EPS Growth(%)-3.04-24.64363.97101.3220.13
Financial Stability Ratios
   Total Debt/Equity(x)0.070.090.130.470.68
   Current Ratio(x)2.742.952.442.212.19
   Quick Ratio(x)1.431.511.340.860.86
   Interest Cover(x)38.6934.2230.045.313.09
   Total Debt/Mcap(x)0.040.030.060.510.58

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.